Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 31, 2001

View Archived Issues

FDA approves insulin analogue for pump therapy

Positive phase I/II AlloMune results for end-stage lymphoma

Kyowa Hakko develops new antibody technology

GeneProt delivers potential protein candidates to Novartis

Preparation and use of new thienopyrimidinediones discovered at AstraZeneca

Uriach researchers identify selective COX-2 inhibitors with antiinflammatory activity

Schering discloses new series of antiangiogenic agents

Novel epothilone derivatives from Schering act as microtubule-stabilizing agents

Vancomycin analogues with activity against enterococci and staphylococci

Inhibitors of shikamate pathway enzyme under development at Arrow as novel antibiotics

Design and preclinical evaluation of a new class of bacterial peptide deformylase inhibitors

Oxapenem beta-lactamase inhibitors reported at ICAAC to extend spectrum of cephalosporins

MitoKor and Pfizer extend mitochondrial dysfunction collaboration

ISV-401 enters phase II trials for bacterial conjunctivitis

Schering and MorphoSys enter therapeutic and diagnostic R&D agreement

AHP and Elan form sleep disorder alliance

Preliminary preclinical data demonstrate tumor vascular targeting efficacy of OXI-4503

Celera and Syrrx enter structural proteomics collaboration